Navigation Links
Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass
Date:1/26/2009

al referral patterns and improved outcomes," said Karen Orloff Kaplan, Sc.D., Chief Executive Officer of the Ovarian Cancer National Alliance.

About HE4

HE4 in a manual format is currently FDA cleared for monitoring recurrent or progressive disease in patients with EOC, and CE-marked in Europe as an aid in estimating the risk of EOC in premenopausal or postmenopausal women presenting with a pelvic mass. The test is currently available in the U.S. exclusively through Quest Diagnostics Incorporated (NYSE: DGX). The HE4 manual test and corresponding Risk of Ovarian Malignancy Algorithm (ROMA(TM)) are pending clearance by the FDA for use in women who present with a pelvic mass.

About Ovarian Cancer

Ovarian cancer is the leading cause of death from gynecologic cancers in the U.S. and the fifth-leading cause of cancer death in women. It accounts for 31% of cancers of the female genital organs. There are an estimated 22,000 new cases annually in the U.S. Women who are postmenopausal are at the greatest risk for ovarian cancer. In their lifetimes, 1 in 72 women will develop ovarian cancer.

Ovarian cancer is difficult to diagnose because its symptoms are easily confused with other non-cancerous conditions: bloating, pelvic or abdominal pain, difficulty eating or feeling full quickly, urgent or frequent urination, gastrointestinal upset and unexplained fatigue. Three quarters of cases of ovarian cancer are diagnosed at an advanced stage, when it is fundamentally incurable. Of patients who are diagnosed early (Stage I-II), more than 90 percent will live past five years. However, only 20 percent of cases are diagnosed in the early stages.

About Fujirebio Diagnostics

Fujirebio Diagnostics is the premier cancer diagnostics company and the industry leader in cancer b
'/>"/>

SOURCE Fujirebio Diagnostics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix
2. MannKind Corporation to Review Positive Results From Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes
3. Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma
4. Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints
5. PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S.
6. Third Pivotal Phase 3 Study for NicOx Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
7. Cell Therapeutics Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint
8. Cell Therapeutics Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial
9. Pivotal Data Showed SYMBICORT(R) Improved Lung Function in Adults with COPD
10. Pivotal Phase III Data Confirm the Efficacy and Safety of Arpidas Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections
11. Sirion Therapeutics Announces Positive Pivotal Uveitis Data for Durezol(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... their offering. Developed by Pharmacia & ... receptor agonist which effectively reduces intraocular pressure. As ... latanoprost (under the trade name of Xalatan) entered ...
(Date:8/28/2015)... , August 28, 2015 The ... in collaboration with one of the leading academics in the ... (current world record holder in life extension for model animals ... into biology of aging and age-related diseases, primarily, around the ... work has just been published as "Stability analysis of a ...
(Date:8/28/2015)... 28, 2015 Perrigo Company plc ("Perrigo") (NYSE: ... N.V. ("Mylan") (NASDAQ: MYL ) shareholder vote regarding ... "Our views of Mylan,s offer to Perrigo shareholders have ... our Board,s careful reflection of the value available to ... choices that Mylan has allowed its shareholders to consider," ...
Breaking Medicine Technology:China Latanoprost Market Investigation Report 2015-2019 2Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5
... , BELLEVUE, Wash., Dec. 1 ... of health, beauty, vision, and pharmacy products, today announced that ... were the highest in company history. This holiday season the ... more special offers than in previous years and their largest ...
... , NEW YORK, ... research report is available in its catalogue: , ... http://www.reportlinker.com/p0164231/Molecular-Diagnostics---A-World-Market-Review.html , Molecular diagnostics market is being ... for automated and easy-to-handle techniques, which combine optimized sample ...
Cached Medicine Technology:drugstore.com, inc. Has Best Day Ever on Cyber Monday 2drugstore.com, inc. Has Best Day Ever on Cyber Monday 3Reportlinker Adds Molecular Diagnostics - A World Market Review 2Reportlinker Adds Molecular Diagnostics - A World Market Review 3Reportlinker Adds Molecular Diagnostics - A World Market Review 4Reportlinker Adds Molecular Diagnostics - A World Market Review 5Reportlinker Adds Molecular Diagnostics - A World Market Review 6Reportlinker Adds Molecular Diagnostics - A World Market Review 7
(Date:8/29/2015)... ... August 29, 2015 , ... People who have heart or ... or asthma, are at higher risk from wildfire smoke especially in Calgary, Alberta.Those ... heart-rhythm problems (arrhythmia or irregular heartbeat) are also sensitive to air pollution. ...
(Date:8/28/2015)... ... ... Rio Salado College joined nine educational institutions in Washington D.C., ... EDUCAUSE - Next Generation Learning Challenges 2015 Breakthrough Models Incubator funded by the ... Incubator hosted by EDUCAUSE and NGLC, which is designed to bring leadership teams ...
(Date:8/28/2015)... FL (PRWEB) , ... August 28, 2015 , ... The ... potential workers are qualified for the position they are applying for, they are unable ... this, many employers are considering altering drug testing policies in order to be able ...
(Date:8/28/2015)... , ... August 28, 2015 ... ... for Medical Devices:, Understanding the FDA’s Position and Best Practices for Compliance, ... http://www.fdanews.com/cybersecuritymd , This workshop, chaired by internationally renowned expert Fubin Wu, ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... or those who might personally be struggling with chemical dependency, may be able ... Best Drug Rehabilitation, a results-driven holistic treatment center for addiction located in Western ...
Breaking Medicine News(10 mins):Health News:Heart Fit Clinic Sounds the Alarm on Forest Fire Smoke and Chronic Heart Disease in Calgary Area 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3
... Receive Training for 350 New Volunteers in Illinois and ... ... on the,rise, there is an increasing need for trained volunteer emergency,responders. Hupy ... the Rescue Riders, a volunteer group of motorcyclists who are,trained in emergency ...
... RIVER, Mass., Aug. 15 Millstone Medical,Outsourcing announced ... division by adding state-of-the-art equipment,increasing inspection staff, and ... 30" comparators, one of which is equipped with ... and a micro-hite. With the new advanced,equipment, Millstone ...
... suggest why some people save while others spend , , FRIDAY, ... much? Both? Don,t blame just the economy or old habits. ... frame of your savings goals, plus your sense of well-being ... your personal cash flow situation. , "Some people think, ,We ...
... half their concerns, so doctors should listen carefully, ... -- Older patients and surgeons don,t communicate effectively ... decision to have surgery can be particularly difficult ... School of Medicine study. , The researchers recorded ...
... Niki Evans lost 18 inches with MYA Cosmetic Surgery. , ... London, UK (PRWEB) August ... had amazing results from having liposuction with http://www.mya.co.uk/ [MYA Cosmetic Surgery]. ... is thrilled with the results of her surgery with MYA and in total ...
... with the FDA, Oligonucleotide Therapeutics Society, Health Canada, and the ... on Oligonucleotide-based Therapeutics (September 22 - 24; Falls Church, VA). ... ... 15, 2008 -- The http://www.diahome.org/ [Drug Information Association ...
Cached Medicine News:Health News:Hupy & Abraham Donation Provides Critical Resource For Motorcyclist Safety 2Health News:Millstone Medical Outsourcing Expands Inspection Services Division, Hires Inspection Manager 2Health News:Money Matters 2Health News:Money Matters 3Health News:Older Adults Reluctant to Question Surgical Treatment 2Health News:X Factor's Niki Evans Amazing Cosmetic Surgery Success 2Health News:X Factor's Niki Evans Amazing Cosmetic Surgery Success 3Health News:Industry Experts and Global Regulators to Discuss Oligonucleotide-Based Therapeutics Issues 2
... Record organizes communication and chart information ... practitioners. It also manages orders, procedures, ... that traditionally rely on many people ... With Microsoft Outlook integration, HealthMatics EMR ...
... Description PANALOK is a fully-absorbable soft ... (polylactic acid) material and provides fixation ... The X-ray transparent anchor retains strength ... and eventually absorbs leaving no permanent ...
... The Bio-Anchor implant is molded from Poly ... absorption rate to insure secure fixation throughout ... eliminates implant removal complications because it is ... be over-drilled. The ribbed, press-fit anchor ...
... just got better. How can one of ... Simply by becoming more convenient to use ... arthroscopic. The TwinFix Suture Anchor with Needles ... unique, convenient and timesaving anchor inserter and ...
Medicine Products: